 |
|
|
| FAR Issue Vol. 44/No. 229 | Section I | |
| Issue Date: November 27, 2018 | ||
|
| Total number of notices in Section I: 3 |
| Notice / Adopted |
Description | ID | Publish Date |
|
|---|---|---|---|---|
|
The proposed rule development is intended to reschedule a drug product in finished dosage formulation that has been approved by the Food and Drug Administration that contains cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1, .... | 21194711 |
11/27/2018 Vol. 44/229 |
|
|
|
The purpose of the revised rule is to clarify the screening process. | 21195390 |
11/27/2018 Vol. 44/229 |
|
|
|
The Department intends to amend 65C-43.002, F.A.C., to update an incorporated reporting tool. | 21195293 |
11/27/2018 Vol. 44/229 |
|